Vaccine Molecules, University of Oslo, EP3678699A1
Summary
The European Patent Office published application EP3678699A1 on April 15, 2026, covering vaccine molecules. The application was filed by the University of Oslo with inventors Gunnveig GRODELAND, Bjarne BOGEN, and Anne Marie ANDERSON. The invention is classified under IPC A61K 39/145 (influenza vaccines), C07K 16/28, C07K 16/44, C07K 14/11, and therapeutic application A61P 31/16. The application designates 31 European and associated states including Germany, France, the United Kingdom, and Italy.
About this source
GovPing monitors EPO Patent Bulletin - Therapeutics (A61P) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 36 changes logged to date.
What changed
The EPO Patent Bulletin published application EP3678699A1 for vaccine molecules, filed by the University of Oslo. The application lists three inventors and covers inventions classified under multiple IPC codes including A61K 39/145 (influenza vaccines), C07K 16/28 (antibodies), and therapeutic application A61P 31/16 (anti-influenza). The application designates 31 European and associated states.
Affected parties include the University of Oslo as applicant, the named inventors, and any entities seeking to develop or license vaccine technology in the designated territories. The publication establishes prior art dates and initiates the examination process for the claimed vaccine molecules.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
VACCINE MOLECULES
Publication EP3678699A1 Kind: A1 Apr 15, 2026
Applicants
University of Oslo
Inventors
GRODELAND, Gunnveig, BOGEN, Bjarne, ANDERSON, Anne Marie
IPC Classifications
A61K 39/145 20060101AFI20190315BHEP C07K 16/28 20060101ALI20190315BHEP C07K 16/44 20060101ALI20190315BHEP C07K 14/11 20060101ALI20190315BHEP A61P 31/16 20060101ALI20190315BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.